Has Geetha Rao, MD received payments from drug or device companies?

Yes. Drug and device makers reported $175 in general payments to Geetha Rao, MD across 1 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Geetha Rao, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Geetha Rao, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Geetha Rao, MD

Geriatric Medicine · Beverly Hills, CANPI 1407983950

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $175 of the $175 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Amgen.

$175in general payments, 2019–2025

Across 1 payment — averaging $175.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$175

What the payments were for

Consulting fees$175100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	1	$175

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Prolia$175

How this compares

$175 in reported general payments places this provider in the 55th percentile of 494 geriatric medicine providers in California.

See all geriatric medicine providers in California →

Medicare billing

Part B allowed, 2024

$466,822

Medicare patients

861

Services billed

30,817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	61	$48,399
MyrbetriqMirabegron	34	$22,330
JanuviaSitagliptin Phosphate	19	$11,579
Memantine Hcl	104	$3,729
Lidocaine	33	$3,583
Mirtazapine	105	$2,523
Atorvastatin Calcium	187	$2,425
Levothyroxine Sodium	172	$1,715
Rosuvastatin Calcium	67	$1,575
Escitalopram Oxalate	101	$1,435
Ventolin HfaAlbuterol Sulfate	21	$1,336
Trazodone Hcl	196	$1,285
Losartan Potassium	122	$1,285
Duloxetine Hcl	27	$1,223
Albuterol Sulfate HfaAlbuterol Sulfate	37	$1,088

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in Beverly Hills

Robert FeldmanLaguna Hills$1.2M
Oscar ChienSan Gabriel$208K
Anders NybergSan Diego$160K
Paul AisenSan Diego$70K
Wayne ChenLos Angeles$40K
Vincent HoLancaster$32K
Kathryn SewellSan Francisco$26K
Stephen HenryPasadena$25K
Chaewon SongGarden Grove$21K
Douglas ZhangSan Leandro$20K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →